Free Trial

Shattuck Labs (STTK) Competitors

Shattuck Labs logo
$1.07 +0.04 (+3.88%)
Closing price 04:00 PM Eastern
Extended Trading
$1.06 -0.01 (-0.93%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STTK vs. CRGX, VYGR, YMAB, IVA, CRDF, PRME, INMB, TLSA, MOLN, and ELDN

Should you be buying Shattuck Labs stock or one of its competitors? The main competitors of Shattuck Labs include CARGO Therapeutics (CRGX), Voyager Therapeutics (VYGR), Y-mAbs Therapeutics (YMAB), Inventiva (IVA), Cardiff Oncology (CRDF), Prime Medicine (PRME), INmune Bio (INMB), Tiziana Life Sciences (TLSA), Molecular Partners (MOLN), and Eledon Pharmaceuticals (ELDN). These companies are all part of the "pharmaceutical products" industry.

Shattuck Labs vs.

Shattuck Labs (NASDAQ:STTK) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, community ranking, analyst recommendations, dividends, earnings and institutional ownership.

58.7% of Shattuck Labs shares are owned by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are owned by institutional investors. 10.5% of Shattuck Labs shares are owned by insiders. Comparatively, 2.9% of CARGO Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Shattuck Labs has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.

Shattuck Labs received 25 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. Likewise, 69.64% of users gave Shattuck Labs an outperform vote while only 66.67% of users gave CARGO Therapeutics an outperform vote.

CompanyUnderperformOutperform
Shattuck LabsOutperform Votes
39
69.64%
Underperform Votes
17
30.36%
CARGO TherapeuticsOutperform Votes
14
66.67%
Underperform Votes
7
33.33%

Shattuck Labs has higher revenue and earnings than CARGO Therapeutics. CARGO Therapeutics is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shattuck Labs$4.61M11.13-$87.30M-$1.39-0.77
CARGO TherapeuticsN/AN/A-$98.15M-$4.62-0.88

Shattuck Labs currently has a consensus target price of $7.50, indicating a potential upside of 600.93%. CARGO Therapeutics has a consensus target price of $15.00, indicating a potential upside of 269.46%. Given Shattuck Labs' stronger consensus rating and higher possible upside, analysts clearly believe Shattuck Labs is more favorable than CARGO Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shattuck Labs
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71
CARGO Therapeutics
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86

CARGO Therapeutics has a net margin of 0.00% compared to Shattuck Labs' net margin of -1,156.46%. CARGO Therapeutics' return on equity of -38.16% beat Shattuck Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Shattuck Labs-1,156.46% -61.92% -54.49%
CARGO Therapeutics N/A -38.16%-33.94%

In the previous week, CARGO Therapeutics had 2 more articles in the media than Shattuck Labs. MarketBeat recorded 2 mentions for CARGO Therapeutics and 0 mentions for Shattuck Labs. CARGO Therapeutics' average media sentiment score of 1.51 beat Shattuck Labs' score of 0.00 indicating that CARGO Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Shattuck Labs Neutral
CARGO Therapeutics Very Positive

Summary

Shattuck Labs beats CARGO Therapeutics on 12 of the 18 factors compared between the two stocks.

Get Shattuck Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STTK vs. The Competition

MetricShattuck LabsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$51.25M$6.49B$5.36B$8.39B
Dividend YieldN/A2.66%5.22%4.10%
P/E Ratio-0.708.9426.5919.72
Price / Sales11.13251.55391.61116.20
Price / CashN/A65.8538.2534.62
Price / Book0.316.466.794.51
Net Income-$87.30M$143.98M$3.23B$248.18M
7 Day Performance18.22%3.16%4.03%1.14%
1 Month Performance36.29%7.60%12.22%15.07%
1 Year Performance-86.14%-2.36%16.76%6.59%

Shattuck Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STTK
Shattuck Labs
2.5855 of 5 stars
$1.07
+3.9%
$7.50
+600.9%
-86.2%$51.25M$4.61M-0.70100Gap Up
CRGX
CARGO Therapeutics
2.211 of 5 stars
$4.07
+1.2%
$15.00
+268.6%
-79.9%$187.67MN/A-0.96116Gap Up
VYGR
Voyager Therapeutics
4.6852 of 5 stars
$3.35
+5.7%
$13.97
+316.9%
-59.8%$185.30M$80.00M4.72100Gap Up
YMAB
Y-mAbs Therapeutics
3.4829 of 5 stars
$4.07
+4.6%
$17.40
+327.5%
-64.2%$184.28M$87.69M-7.54150Analyst Forecast
Analyst Revision
Gap Up
IVA
Inventiva
1.5119 of 5 stars
$3.51
-3.0%
$10.40
+196.3%
-17.1%$184.19M$9.20M0.00100Gap Down
CRDF
Cardiff Oncology
1.5769 of 5 stars
$2.75
+3.4%
$12.00
+336.4%
-13.3%$182.95M$683,000.00-2.9320News Coverage
Gap Up
PRME
Prime Medicine
3.7245 of 5 stars
$1.34
+3.1%
$13.14
+880.8%
-84.4%$175.76M$3.85M-0.65234Trending News
Analyst Forecast
Analyst Revision
Gap Down
INMB
INmune Bio
1.9905 of 5 stars
$7.64
+9.6%
$22.80
+198.4%
-31.6%$175.60M$14,000.00-3.5010Gap Up
TLSA
Tiziana Life Sciences
1.081 of 5 stars
$1.50
-4.5%
N/A+94.8%$175.27MN/A0.008Gap Up
MOLN
Molecular Partners
1.977 of 5 stars
$4.28
+4.4%
$12.00
+180.4%
+5.6%$172.81M$4.97M-1.99180News Coverage
Earnings Report
Analyst Revision
Gap Up
ELDN
Eledon Pharmaceuticals
2.1648 of 5 stars
$2.87
-0.7%
$12.50
+335.5%
-1.9%$171.86MN/A-1.4310Trending News
Earnings Report
Analyst Revision
Gap Up

Related Companies and Tools


This page (NASDAQ:STTK) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners